PUBLISHER: Grand View Research | PRODUCT CODE: 1611718
PUBLISHER: Grand View Research | PRODUCT CODE: 1611718
The global lactose-free infant formula market size is expected to reach USD 33.08 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 6.6% from 2025 to 2030. Growing population of lactose intolerant newborns at the global level is a key factor driving the market.
Increasing working women population is also significantly affecting the market growth. Companies are investing on research and development to increase their focus on lactose-Free Infant Formula product offerings. For instance, Valio Oy has introduced more than 100 lactose free products in 50 countries. In 2016, the company invested around USD 28.0 million on new product development in order to provide high quality assurance to the customers.
The organic category held the largest market share in 2024. The segment growth is attributed to rising demand for premium products in the market. Increasing awareness about the side effects of chemically synthesized products is also driving the consumers to purchase organic products. The conventional category is anticipated to witness significant growth due to its cost effectiveness and availability of the product in the market. The product witnesses majority of its demand from the regions including Asia Pacific and Central and South America.
Supermarkets & hypermarkets segment held the largest revenue share of the global lactose-free infant formula industry in 2024. Availability of a wide product line is a major factor driving the consumers to purchase their products from this channel. The online category is anticipated to emerge as the fastest growing category. Consumers are shifting their preference toward online purchase due to the convenience of doorstep delivery services.
Europe is the largest consumer of lactose-Free Infant Formula. In 2024, the region accounted for 35.0% share of the global revenue. Europeans prefer purchasing these products as they help in preventing diseases like diarrhea among newborns. In Finland, one out of 60,000 newborns are lactose intolerant, which, in turn, is driving the market. Some of the key players operating in the Europe market are GIMME THE GOOD STUFF and Abbott.
The lactose-Free Infant Formula market is competitive in nature due to the presence of many small and large players. Some of the major companies operating in this market are Nestle; Nutricia; Valio Oy; Abbott; GIMME THE GOOD STUFF; Silverson; Apta Advice; Danone; and Nurture, Inc.